aod9604 clinical trials efficacy side effects AOD-9604 Before and After: Results AOD-9604 (10mg vials) - Peptide
Description
The compliance question is not the law, it is the source
Am Fam Physician 96
The precursor provides raw material for NAD+ synthesis while 5-amino-1mq prevents NNMT from draining the nicotinamide pool
Mixed Clinical Efficacy The clinical trial history of AOD-9604 is mixed
Week 24 Noticeable reduction in food cravings and portion sizes
Other growth hormone fragments have been investigated, but AOD-9604 benefits from the most extensive clinical safety database
